Highlights and Quick Summary
- EPS (Diluted, Consolidated) for the quarter ending September 30, 2022 was $-0.228 (a -27.97% decrease compared to previous quarter)
- Year-over-year quarterly EPS (Diluted, Consolidated) increased by 142.21%
- Annual EPS (Diluted, Consolidated) for 2021 was $-1.03 (a -5.97% decrease from previous year)
- Annual EPS (Diluted, Consolidated) for 2020 was $-1.09 (a 16.02% increase from previous year)
- Annual EPS (Diluted, Consolidated) for 2019 was $-0.942 (a -4.0% decrease from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted, Consolidated) of BioCryst Pharmaceuticals, Inc.
Most recent EPS (Diluted, Consolidated)of BCRX including historical data for past 10 years.Interactive Chart of EPS (Diluted, Consolidated) of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. EPS (Diluted, Consolidated) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.0 | $0.0 | $0.0 | – |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2018 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2017 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2016 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2015 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2014 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2013 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2012 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology